Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials.
Saved in:
| Title: | Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials. |
|---|---|
| Authors: | Rodriguez GD; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA.; Columbia University School of Nursing, New York, NY, USA., Warren N; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA., Yashayev R; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA., Chitra S; Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA., Amodio-Groton M; Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA., Wright K; Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA. Kelly.Wright@paratekpharma.com. |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2024 Dec; Vol. 13 (12), pp. 2637-2648. Date of Electronic Publication: 2024 Oct 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
